Bruker Corporation $BRKR Shares Sold by Alliancebernstein L.P.

Key Points

• Alliancebernstein L.P. has reduced its holdings in Bruker Corporation by 12.4%, selling 339,351 shares and now owning 2,390,366 shares valued at approximately $99.77 million.
• Bruker recently reported earnings of $0.32 per share for the quarter, missing expectations by $0.01, with revenue of $797.40 million, also below consensus estimates.
• The firm announced a quarterly dividend of $0.05 per share, representing an annual yield of 0.6%, with a payout ratio of 38.46%.

Alliancebernstein L.P. reduced its holdings in Bruker Corporation (NASDAQ:BRKR - Free Report) by 12.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,390,366 shares of the medical research company's stock after selling 339,351 shares during the quarter. Alliancebernstein L.P. owned 1.58% of Bruker worth $99,774,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in BRKR. Teacher Retirement System of Texas increased its position in shares of Bruker by 5.1% during the 1st quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company's stock valued at $1,212,000 after purchasing an additional 1,422 shares during the period. Fifth Third Bancorp increased its position in shares of Bruker by 54.2% during the 1st quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company's stock valued at $46,000 after purchasing an additional 390 shares during the period. Wealth Enhancement Advisory Services LLC increased its position in shares of Bruker by 81.2% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company's stock valued at $1,245,000 after purchasing an additional 13,367 shares during the period. OneDigital Investment Advisors LLC increased its position in shares of Bruker by 38.0% during the 1st quarter. OneDigital Investment Advisors LLC now owns 5,522 shares of the medical research company's stock valued at $230,000 after purchasing an additional 1,520 shares during the period. Finally, UMB Bank n.a. grew its holdings in shares of Bruker by 45.8% in the 1st quarter. UMB Bank n.a. now owns 1,325 shares of the medical research company's stock worth $55,000 after acquiring an additional 416 shares during the last quarter. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on BRKR shares. Bank of America dropped their price target on Bruker from $61.00 to $50.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. Stifel Nicolaus set a $40.00 price target on Bruker and gave the company a "hold" rating in a research report on Tuesday, August 5th. Jefferies Financial Group set a $60.00 price target on Bruker and gave the company a "buy" rating in a research report on Monday, August 4th. Wells Fargo & Company dropped their price target on Bruker from $60.00 to $50.00 and set an "overweight" rating on the stock in a research report on Tuesday, August 5th. Finally, Citigroup dropped their price target on Bruker from $40.00 to $38.00 and set a "neutral" rating on the stock in a research report on Monday, August 4th. Five analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $51.30.

Bruker Price Performance

Shares of NASDAQ:BRKR opened at $30.83 on Friday. The business has a 50 day moving average price of $37.12 and a 200 day moving average price of $39.68. Bruker Corporation has a twelve month low of $28.53 and a twelve month high of $72.94. The company has a market cap of $4.68 billion, a price-to-earnings ratio of 59.29, a PEG ratio of 3.71 and a beta of 1.21. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its earnings results on Monday, August 4th. The medical research company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.33 by ($0.01). Bruker had a net margin of 2.31% and a return on equity of 17.89%. The business had revenue of $797.40 million for the quarter, compared to the consensus estimate of $811.17 million. During the same quarter in the previous year, the company earned $0.52 EPS. Bruker's revenue for the quarter was down .4% compared to the same quarter last year. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Research analysts predict that Bruker Corporation will post 2.69 earnings per share for the current year.

Bruker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 3rd. Investors of record on Tuesday, September 23rd will be paid a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 23rd. This represents a $0.20 annualized dividend and a yield of 0.6%. Bruker's dividend payout ratio is presently 38.46%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.